Mylan N Profit Margin

MYL -- USA Stock  

USD 19.03  0.14  0.73%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Mylan N Profit Margin Analysis

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Profit Margin 
Net Income 
More About Profit Margin | All Equity Analysis
Mylan N Profit Margin  =
Mylan N ValuationFundamentalsBuy or Sell

Profit Margin Over Time Pattern

 Mylan N Profit Margin 

About Profit Margin

In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Compare to competition

Mylan N Profit Margin Assessment

Based on latest financial disclosure Mylan N V has Profit Margin of 2.14%. This is 119.09% lower than that of the Healthcare sector, and 136.15% lower than that of Drug Manufacturers - Specialty & Generic industry, The Profit Margin for all stocks is 268.5% lower than the firm.

Did you try this?

Run Portfolio Backtesting Now


Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

Mylan N current financial ratios